Company Growth (employees)
CureVac was founded in 2000 and is headquartered in Tübingen, DE
Key People/Management at CureVac
Ingmar Hoerr
Chief Executive Officer
Mathias Hothum
Baord of Directors
Franz-Werner Haas
Chief Corporate Officer
Ulrike Gnad-Vogt
Acting Chief Medical Officer
Mariola Fotin-Mleczek
Acting Chief Scientific Officer
CureVac Office Locations
CureVac has offices in Tübingen, Frankfurt am Main and Boston
Tübingen, DE (HQ)
Paul-Ehrlich-Str. 15
Boston, US
51 Melcher St
Frankfurt am Main, DE
27 Schumannstraße
Tübingen, DE
15 Paul-Ehrlich-Straße
CureVac Financials and Metrics
Summary Metrics
Founding Date | 2000 |
Total Funding | $359 m |
Latest funding size | $29.5 m |
Time since last funding | 11 months |
Investors | Bill & Melinda Gates Foundation, DH Capital, dievini Hopp Biotech Holding, OH Beteiligungen, Sigma Group, Baillie Gifford, LBBW Asset Management, Northview LifeSciences, Chartwave, Landeskreditbank Baden-Württemberg, Baden-Württembergische Versorgungsanstalt für Ärzte, Coppel Family |
CureVac's latest funding round in November 2016 was reported to be $29.5 m. In total, CureVac has raised $359 m. CureVac's latest valuation is reported to be $1.7 b.
CureVac Financials
USD
Market valuation | 1.7 b |
Market Position of CureVac
Traffic Overview of CureVac
CureVac Online and Social Media Presence
CureVac News and Updates
June 19, 2017
Pharma’s Future: 100+ Startups Working Across Alzheimer’s, Diabetes, Cancer, And More
The pharmaceutical industry is changing at a rapid pace. The introduction of immunotherapy techniques such as CAR-T cell therapy and cancer vaccines are bringing oncology into the 21st century while CRISPR is poised to bring genetic editing into every clinic … Continued